# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY

I Background Information:

# B Applicant

Siemens Healthcare Diagnostics, Inc.

# C Proprietary and Established Names

Emit $\textsuperscript { \textregistered }$ II Plus Buprenorphine Assay

D Regulatory Information

<table><tr><td rowspan=1 colspan=1>ProductCode(s)</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>RegulationSection</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>DJG</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR 862.3650 - OpiateTest System</td><td rowspan=1 colspan=1>TX - Clinical Toxicology</td></tr></table>

II Submission/Device Overview:

A Purpose for Submission: Modified device   
B Measurand: Buprenorphine   
C Type of Test: Qualitative and semiquantitative immunoassay

III Intended Use/Indications for Use:

A Intended Use(s):

See Indication(s) for Use below.

# B Indication(s) for Use:

The Emit $\textsuperscript { \textregistered }$ II Plus Buprenorphine Assay is a homogeneous enzyme immunoassay with a 5 $\mathrm { n g / m L }$ cutoff. The assay is intended for use in laboratories for the qualitative and/or semiquantitative analyses of buprenorphine in human urine. Emit $\textsuperscript { \textregistered }$ II Plus assays are designed for use with a number of chemistry analyzers.

The semiquantitative mode is for the purpose of enabling laboratories to determine an appropriate dilution of the specimen for confirmation by a confirmatory method such as Liquid Chromatography/Mass Spectrometry (LC/MS) or permitting laboratories to establish quality control procedures.

The Emit $\textsuperscript { \textregistered }$ II Plus Buprenorphine Assay provides only a preliminary analytical test result. A more specific alternative chemical method(s) must be used to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) or LC/MS are the preferred confirmatory methods. Other chemical confirmation methods are available. Clinical consideration and professional judgment should be applied to any drug-of-abuse test result, particularly when preliminary positive results are used.

For Professional Use.

Caution: Federal (USA) law restricts this device to sale by or on the order of a licensed healthcare professional.

For in vitro diagnostic use.

# C Special Conditions for Use Statement(s):

For Prescription Use Only.

D Special Instrument Requirements:

All performance studies were conducted on the DxC 500 AU Clinical Chemistry Analyzer.

# IV Device/System Characteristics:

# A Device Description:

The Emit $\textsuperscript { \textregistered }$ II Plus Buprenorphine Assay is a homogeneous enzyme immunoassay consisting of the following components:

# Antibody/Substrate

# Reagent 1

Mouse monoclonal antibodies to buprenorphine $( 0 . 5 3 ~ \mu \mathrm { g / m L }$ ) NAD $( 6 . 9 \mathrm { m M } )$ , G6P (10.9 mM), bovine serum albumin, preservatives, and stabilizers.

# Enzyme

# Reagent 2

Norbuprenorphine labeled with bacterial rG6PDH $( 0 . 5 0 \mu \mathrm { g / m L }$ ), HEPES buffer, bovine serum albumin, preservatives, and stabilizers.

# B Principle of Operation:

The Emit $\textsuperscript { \textregistered }$ II Plus Buprenorphine Assay is a homogenous enzyme immunoassay. The assay is based upon competition between drug in the specimen and drug labeled with the recombinant glucose-6-phosphate dehydrogenase (rG6PDH) for the antibody binding sites. Active enzyme converts nicotinamide adenine dinucleotide (NAD) to NADH in the presence of glucose-6- phosphate (G6P), resulting in an absorbance change that is measured spectrophotometrically.

V Substantial Equivalence Information:

A Predicate Device Name(s): Emit $\textsuperscript { \textregistered }$ II Plus Buprenorphine Assay B Predicate 510(k) Number(s): K150606 C Comparison with Predicate(s):

<table><tr><td rowspan=1 colspan=1>Device &amp; PredicateDevice(s):</td><td rowspan=1 colspan=1>Emit® II PlusBuprenorphine Assay(K221605)</td><td rowspan=1 colspan=1>Emit® II PlusBuprenorphine Assay(K150606)</td></tr><tr><td rowspan=1 colspan=1>Device Trade Name</td><td rowspan=1 colspan=1>Emit® II PlusBuprenorphine Assay</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>General DeviceCharacteristic Similarities</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Intended Use/IndicationsFor Use</td><td rowspan=1 colspan=1>A homogeneous enzymeimmunoassay with a 5ng/ml cutoff. The assayis intended for use inlaboratories for thequalitative and/orsemiquantitative analysesof buprenorphine inhuman urine.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>General DeviceCharacteristic Differences</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>Instrument</td><td rowspan=1 colspan=1>DxC 500 AU ClinicalChemistry Analyzer</td><td rowspan=1 colspan=1>Viva-E Analyzer</td></tr></table>

# VI Standards/Guidance Documents Referenced:

CLSI Guideline EP09c, Measurement Procedure Comparison and Bias Estimation Using Patient Samples – Third Edition

CLSI Guideline EP12-A2, User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline—Second Edition

CLSI EP05-A3, Evaluation of Precision of Quantitative Measurement Procedures: Approved Guideline -Third Edition.

CLSI Guideline EP17-A2, Evaluation of Detection Capability for Clinical Laboratory Measurement Procedures; Approved Guideline – Second Edition

CLSI Guideline EP07, Interference Testing in Clinical Chemistry.- Third Edition

# VII Performance Characteristics (if/when applicable):

# 1. Analytical Performance:

a. Precision/Repeatability and Within-lab Precision:

Repeatability and within lab precision studies were conducted using urine pools spiked with Buprenorphine into drug free human urine at 11 concentrations. For each level, samples were analyzed in duplicate twice a day, for 20 days $( \mathrm { N } { = } 8 0 )$ . The precision study design was guided by recommendations in CLSI EP05-A3. The results are summarized below for the qualitative and semi-quantitative analyses.

Precision: Qualitative mode   

<table><tr><td rowspan=1 colspan=1>Sample Conc.(ng/mL)</td><td rowspan=1 colspan=1>% of theCutoff</td><td rowspan=1 colspan=1># ofResults</td><td rowspan=1 colspan=1>RepeatabilityResults(Pos/Neg)</td><td rowspan=1 colspan=1>Within-Lab(Pos/Neg)</td></tr><tr><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Negative</td><td rowspan=1 colspan=1>80 Negative</td></tr><tr><td rowspan=1 colspan=1>1.25</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Negative</td><td rowspan=1 colspan=1>80 Negative</td></tr><tr><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Negative</td><td rowspan=1 colspan=1>80 Negative</td></tr><tr><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>-40%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Negative</td><td rowspan=1 colspan=1>80 Negative</td></tr><tr><td rowspan=1 colspan=1>3.75</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Negative</td><td rowspan=1 colspan=1>80 Negative</td></tr><tr><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>21 Negative59 Positive</td><td rowspan=1 colspan=1>21 Negative59 Positive</td></tr><tr><td rowspan=1 colspan=1>6.25</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Negative</td><td rowspan=1 colspan=1>80 Negative</td></tr><tr><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>+40%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Negative</td><td rowspan=1 colspan=1>80 Negative</td></tr><tr><td rowspan=1 colspan=1>7.5</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Negative</td><td rowspan=1 colspan=1>80 Negative</td></tr><tr><td rowspan=1 colspan=1>8.75</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Negative</td><td rowspan=1 colspan=1>80 Negative</td></tr><tr><td rowspan=1 colspan=1>10.0</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80 Negative</td><td rowspan=1 colspan=1>80 Negative</td></tr></table>

Precision: Semi-quantitative mode   

<table><tr><td rowspan=1 colspan=5></td><td rowspan=1 colspan=2>Repeatability</td><td rowspan=1 colspan=2>Within-LabPrecision</td></tr><tr><td rowspan=1 colspan=1>SampleConc.(ng/mL)</td><td rowspan=1 colspan=1>% oftheCutoff</td><td rowspan=1 colspan=1># ofResults</td><td rowspan=1 colspan=1>Results(Pos/Neg)</td><td rowspan=1 colspan=1>Mean(ng/mL)</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80Negative</td><td rowspan=1 colspan=1>0.1</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>-</td><td rowspan=1 colspan=1>0.11</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>1.25</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80Negative</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>6.6</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>6.6</td></tr><tr><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80Negative</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>0.09</td><td rowspan=1 colspan=1>3.7</td><td rowspan=1 colspan=1>0.11</td><td rowspan=1 colspan=1>4.6</td></tr><tr><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>-40%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80Negative</td><td rowspan=1 colspan=1>2.7</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>2.8</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>5.7</td></tr><tr><td rowspan=1 colspan=1>3.75</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80Negative</td><td rowspan=1 colspan=1>3.3</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>4.4</td></tr><tr><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>0%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>21Negative59Positive</td><td rowspan=1 colspan=1>5.1</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>0.18</td><td rowspan=1 colspan=1>3.5</td></tr><tr><td rowspan=1 colspan=1>6.25</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80Negative</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>0.11</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>0.21</td><td rowspan=1 colspan=1>3.4</td></tr><tr><td rowspan=1 colspan=1>7.0</td><td rowspan=1 colspan=1>+40%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80Negative</td><td rowspan=1 colspan=1>6.8</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>0.24</td><td rowspan=1 colspan=1>3.5</td></tr><tr><td rowspan=1 colspan=1>7.5</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80Negative</td><td rowspan=1 colspan=1>7.3</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>0.21</td><td rowspan=1 colspan=1>2.9</td></tr><tr><td rowspan=1 colspan=1>8.75</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80Negative</td><td rowspan=1 colspan=1>8.8</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>0.24</td><td rowspan=1 colspan=1>2.8</td></tr><tr><td rowspan=1 colspan=1>10.0</td><td rowspan=1 colspan=1>100%</td><td rowspan=1 colspan=1>80</td><td rowspan=1 colspan=1>80Negative</td><td rowspan=1 colspan=1>9.7</td><td rowspan=1 colspan=1>0.10</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>0.37</td><td rowspan=1 colspan=1>3.8</td></tr></table>

Reproducibility studies were conducted with urine samples at 3 concentration levels using the semi-quantitative mode. Samples were assayed in 5 replicates in 1 run for 5 days using 3 instruments and 3 reagent lots. The data were analyzed to calculate the following components of precision: repeatability, between-day, between-lot, between-instrument, and total reproducibility.

<table><tr><td rowspan=1 colspan=3></td><td rowspan=1 colspan=2>Repeatability</td><td rowspan=1 colspan=2>Between-day</td><td rowspan=1 colspan=2>Between-lot</td></tr><tr><td rowspan=1 colspan=1>UrineConc.(ng/mL)</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean(ng/mL)</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>0.11</td><td rowspan=1 colspan=1>3.6</td><td rowspan=1 colspan=1>0.06</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>0.03</td><td rowspan=1 colspan=1>0.8</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>0.11</td><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>0.07</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>0.00</td><td rowspan=1 colspan=1>0.0</td></tr><tr><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>7.1</td><td rowspan=1 colspan=1>0.12</td><td rowspan=1 colspan=1>1.70</td><td rowspan=1 colspan=1>0.08</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>0.05</td><td rowspan=1 colspan=1>0.15</td></tr></table>

<table><tr><td rowspan=1 colspan=3></td><td rowspan=1 colspan=2>Between-instrument</td><td rowspan=1 colspan=2>Total Reproducibility</td></tr><tr><td rowspan=1 colspan=1>UrineConc.(ng/mL)</td><td rowspan=1 colspan=1>N</td><td rowspan=1 colspan=1>Mean(ng/mL)</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>%CV</td></tr><tr><td rowspan=1 colspan=1>3</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>0.11</td><td rowspan=1 colspan=1>3.4</td><td rowspan=1 colspan=1>0.17</td><td rowspan=1 colspan=1>5.3</td></tr><tr><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>0.13</td><td rowspan=1 colspan=1>2.6</td><td rowspan=1 colspan=1>0.18</td><td rowspan=1 colspan=1>3.7</td></tr><tr><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>7.1</td><td rowspan=1 colspan=1>0.15</td><td rowspan=1 colspan=1>2.1</td><td rowspan=1 colspan=1>0.21</td><td rowspan=1 colspan=1>3.0</td></tr></table>

# b. Linearity/assay reportable range:

Drug free urine pools were spiked with nine concentrations of buprenorphine at levels 2.2 - $2 5 . 6 \mathrm { n g / m L }$ and analyzed semi-quantitatively in five replicates using the Emit $\textsuperscript { \textregistered }$ II Plus Buprenorphine Assay system. The mean observed buprenorphine concentration was compared to the expected Buprenorphine concentration and percent recovery results shown in the table below. Expected concentrations were confirmed by Liquid Chromatography/Tandem Mass Spectrometry.

<table><tr><td rowspan=1 colspan=1>Expected BuprenorphineConc (ng/mL)</td><td rowspan=1 colspan=1>Mean Buprenorphine Conc.by Emit® II PlusBuprenorphine Assay(ng/mL)</td><td rowspan=1 colspan=1>% Recovery</td></tr><tr><td rowspan=1 colspan=1>2.2</td><td rowspan=1 colspan=1>1.9</td><td rowspan=1 colspan=1>86</td></tr><tr><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>91</td></tr><tr><td rowspan=1 colspan=1>4.4</td><td rowspan=1 colspan=1>4.1</td><td rowspan=1 colspan=1>93</td></tr><tr><td rowspan=1 colspan=1>5.1</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>96</td></tr><tr><td rowspan=1 colspan=1>8.8</td><td rowspan=1 colspan=1>7.6</td><td rowspan=1 colspan=1>86</td></tr><tr><td rowspan=1 colspan=1>13.1</td><td rowspan=1 colspan=1>11.6</td><td rowspan=1 colspan=1>89</td></tr><tr><td rowspan=1 colspan=1>18.1</td><td rowspan=1 colspan=1>18.1</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>22.9</td><td rowspan=1 colspan=1>22.9</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>25.6</td><td rowspan=1 colspan=1>24.7</td><td rowspan=1 colspan=1>96</td></tr></table>

# c. Analytical Specificity/Interference:

The experimental design was one (1) reagent lot, one (1) calibrator lot, one (1) instrument, one (1) sample pool for each compound tested. The samples were assayed in five (5) replicates. The samples were evaluated on the DxC 500 AU Clinical Chemistry Analyzer.

# Buprenorphine Metabolite Recovery:

Buprenorphine and the buprenorphine metabolites: norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide were spiked into aliquots of drug free urine

at the levels shown and run in replicates of 5. The samples were assayed, and the mean recovery results were determined and shown in the table below.

Buprenorphine and Buprenorphine Metabolites Recovery   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Conc. tested(ng/mL)</td><td rowspan=1 colspan=1>Mean(ng/mL)</td><td rowspan=1 colspan=1>Cutoff(ng/mL)</td><td rowspan=1 colspan=1>% Cross-reactivity</td></tr><tr><td rowspan=1 colspan=1>Buprenorphine</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>4.9</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>98%</td></tr><tr><td rowspan=1 colspan=1>Norbuprenorphine</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>5.3</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>106%</td></tr><tr><td rowspan=1 colspan=1>BuprenorphineGlucuronide</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>0.10%</td></tr><tr><td rowspan=1 colspan=1>NorbuprenorphineGlucuronide</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>0.10%</td></tr></table>

# Structurally Related Compounds:

Samples were prepared by spiking drug-free human urine with individual cross-reactants to the targeted level. The samples were evaluated on the DxC 500 AU analyzer. All samples were tested in replicates of 5.

Cross-Reactivity with the Structurally Related Drugs   

<table><tr><td colspan="1" rowspan="1">Compound</td><td colspan="1" rowspan="1">Conc.Tested(ng/mL)</td><td colspan="1" rowspan="1">Qual. Result(Pos/Neg)</td><td colspan="1" rowspan="1">Semi-quant.Result(Pos/Neg)</td><td colspan="1" rowspan="1">% Cross-reactivity</td></tr><tr><td colspan="1" rowspan="1">6-acetylcodeine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">6-acetylmorphine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Dihydrocodeine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Ethyl Morphine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Heroin</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Hydrocodone</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Hydromorphone</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Levorphanol</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Morphine 3-glucuronide</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Morphine 6-glucuronide</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Nalorphine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Norcodeine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Normorphine</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Noroxycodone</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Noroxymorphone</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Oxycodone</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr><tr><td colspan="1" rowspan="1">Oxymorphone</td><td colspan="1" rowspan="1">100000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">&lt;0.01</td></tr></table>

# Structurally Unrelated Compounds:

The following structurally unrelated compounds were added into drug-free urine spiked with the measurand to form two concentration levels, $\pm 4 0 \%$ $\mathrm { 3 n g / m L }$ and $7 \mathrm { n g / m L }$ , respectively) of the cutoff concentration. All samples were tested in 5 replicates. The substances listed in the table below do not yield a false response relative to the cutoff in both qualitative and semi-quantitative mode.

<table><tr><td colspan="1" rowspan="2">Interference(Structurally UnrelatedCompounds</td><td colspan="1" rowspan="2">Conc.Tested(μg/mL)</td><td colspan="2" rowspan="1">-40% Cutoff( 3 ng/mL)</td><td colspan="2" rowspan="1">+40% Cutoff( 7 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Qualit.ResultPos/Neg</td><td colspan="1" rowspan="1">Semi-quant.ResultPos/Neg</td><td colspan="1" rowspan="1">Qualit.ResultPos/Neg</td><td colspan="1" rowspan="1">Semi-quant.ResultPos/Neg</td></tr><tr><td colspan="1" rowspan="1">10, 11-dihydrocarbamazepine</td><td colspan="1" rowspan="1">85</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic Acid</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Amitriptyline</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">ZT (Zidovudine)</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Brompheniramine</td><td colspan="1" rowspan="1">75</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Captopril</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Chlordiazepoxide</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Cimetidine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Clomipramine</td><td colspan="1" rowspan="1">2.5</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Cyclobenzaprine</td><td colspan="1" rowspan="1">125</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">d-amphetamine</td><td colspan="1" rowspan="1">700</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Desipramine</td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Diazepam</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">0.01</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">d-methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Doxepin</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">EDDP</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">EMDP</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Enalapril</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Fluoxetine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Glutethimide</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Haloperidol</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Hydroxyzine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Imipramine</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">KetorolacTromethamine</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">LAAM (L-a-acetylmethadol)</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">L-Cotinine</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Levofloxacin</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Levothyroxine (L-Thyroxine)</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Lidocaine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Lormetazepam</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">LSD</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">MDMA (Ecstasy)</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Methaqualone</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">NAPA</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Nicotinic Acid</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Nordiazepam</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Nortriptyline</td><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Perphenazine</td><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Phencyclidine</td><td colspan="1" rowspan="1">900</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Phenobarbital</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Phenelzine</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Phenytoin</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Procainamide</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Procyclidine</td><td colspan="1" rowspan="1">800</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Promethazine</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Propoxyphene</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Protriptyline</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Pseudoephedrine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Quinacrine</td><td colspan="1" rowspan="1">900</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Ranitidine</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Ritalin</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Salicylic Acid</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Scopolamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Tapetal</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">THC</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Thioridazine</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Tramadol</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Trazodone</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Trimethoprim</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Triprolidine (zymine)</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Tyramine</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Verapamil</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr><tr><td colspan="1" rowspan="1">Zolpidem</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Neg</td><td colspan="1" rowspan="1">Pos</td><td colspan="1" rowspan="1">Pos</td></tr></table>

# Endogenous Substances Interference:

Each compound was spiked into samples with $- 4 0 \%$ cutoff and $+ 4 0 \%$ cutoff concentration pools which were prepared by spiking buprenorphine to aliquots of drug-free human urine. The results show that the tested endogenous substances at the levels tested caused no interference relative to the $5 \mathrm { n g / m L }$ cutoff. Testing was conducted using both the qualitative and semi-quantitative modes. Results are provided in the table below.

<table><tr><td rowspan=2 colspan=1>InterferenceEndogenousSubstances</td><td rowspan=2 colspan=1>Conc.Tested(μg/mL)</td><td rowspan=1 colspan=2>-40% Cutoff(3 ng/mL)</td><td rowspan=1 colspan=2>+40% Cutoff( 7 ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Qualit.ResultPos/Neg</td><td rowspan=1 colspan=1>Semi-quant.ResultPos/Neg</td><td rowspan=1 colspan=1>Qualit.ResultPos/Neg</td><td rowspan=1 colspan=1>Semi-quant.ResultPos/Neg</td></tr><tr><td rowspan=1 colspan=1>Acetone</td><td rowspan=1 colspan=1>1.0 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>1.5 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>ConjugatedBilirubin</td><td rowspan=1 colspan=1>2.0 mg/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>UnconjugatedBilirubin</td><td rowspan=1 colspan=1>2.0 mg/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>0.5 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1.0 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>IgG</td><td rowspan=1 colspan=1>0.5 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>2.0 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>115 mg/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Human SerumAlbumin</td><td rowspan=1 colspan=1>0.5 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Oxalic Acid</td><td rowspan=1 colspan=1>0.1 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Riboflavin</td><td rowspan=1 colspan=1>7.5 mg/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Sodium Chloride</td><td rowspan=1 colspan=1>6.0 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>6.0 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Sodium Azide</td><td rowspan=1 colspan=1>1% w/v</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Sodium Fluoride</td><td rowspan=1 colspan=1>1% w/v</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr><tr><td rowspan=1 colspan=1>Galactose</td><td rowspan=1 colspan=1>1.0 g/dL</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Neg</td><td rowspan=1 colspan=1>Pos</td><td rowspan=1 colspan=1>Pos</td></tr></table>

# Specific Gravity and pH:

Negative urine pools with specific gravity values ranging from 1.002–1.035 and $\mathsf { p H }$ values ranging from 3.0–11.0 were tested in the presence of two levels of controls at $+ / - 4 0 \%$ (3 and $7 ~ \mathrm { n g / m L ) }$ ) of the cutoff concentration. All samples were tested in triplicates and no interference was observed.

d. Assay Reportable Range: See linearity section (1 b.) above.

e. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods):

Emit $\textsuperscript { \textregistered }$ II Plus Specialty Drug Calibrator/Control is traceable to a commercially available standard.

f. Detection Limit:

Not applicable.

g. Assay Cut-Off:

Analytical performance of the device around the claimed cutoff is described in the precision section (section VII, A1) above.

# 2. Comparison Studies:

# a. Method comparison

One-hundred twenty (120) unaltered human urine samples were qualitatively and semiquantitatively evaluated using the Emit $\textsuperscript { \textregistered }$ II Plus Buprenorphine Assay system and compared with the results obtained by the reference method LC/MS/MS. The results are presented below:

Emit $\textsuperscript { \textregistered }$ II Plus Buprenorphine Assay vs. LC/MS/MS Comparison Table for Qualitative and Semi-quantitative Assay Performance   

<table><tr><td colspan="1" rowspan="1"></td><td colspan="4" rowspan="1">LC/MS/MS</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Negative (&lt;2.5ng/mL)</td><td colspan="1" rowspan="1">NegativeWithin50% below thecutoff(2.5 - 4.9 ng/mL)</td><td colspan="1" rowspan="1">PositiveWithin50% above thecutoff(5.0-7.5 ng/mL)</td><td colspan="1" rowspan="1">Positive (&gt;7.5ng/mL)</td></tr><tr><td colspan="3" rowspan="1">Qualitative</td><td colspan="2" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Emit®Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">40</td></tr><tr><td colspan="1" rowspan="1">Emit®Negative</td><td colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr><tr><td colspan="5" rowspan="1">Semiquantitative</td></tr><tr><td colspan="1" rowspan="1">Emit®Positive</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">9</td><td colspan="1" rowspan="1">23</td><td colspan="1" rowspan="1">40</td></tr><tr><td colspan="1" rowspan="1">Emit®Negative</td><td colspan="1" rowspan="1">32</td><td colspan="1" rowspan="1">16</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td></tr></table>

Discordant Samples LC/MS/MS Analysis Results   

<table><tr><td rowspan=2 colspan=1>SampleID</td><td rowspan=2 colspan=1>DxC 500AU(ng/mL)</td><td rowspan=1 colspan=2>LC/MS/MS</td><td rowspan=2 colspan=1>Emit +/-</td><td rowspan=2 colspan=1>LC/MS/MS+/-</td></tr><tr><td rowspan=1 colspan=1>Bup(ng/mL)</td><td rowspan=1 colspan=1>NorBup(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>BUP35</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4.2</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>BUP45</td><td rowspan=1 colspan=1>6.0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4.6</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>BUP51</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4.3</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>BUP60</td><td rowspan=1 colspan=1>5.6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3.8</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>BUP62</td><td rowspan=1 colspan=1>6.1</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>3.9</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1>-</td></tr><tr><td rowspan=1 colspan=1>BUP87</td><td rowspan=1 colspan=1>5.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4.3</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>BUP95</td><td rowspan=1 colspan=1>5.6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4.5</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>BUP101</td><td rowspan=1 colspan=1>6.3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4.8</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>BUP109</td><td rowspan=1 colspan=1>5.0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4.3</td><td rowspan=1 colspan=1>+</td><td rowspan=1 colspan=1></td></tr></table>

Bup $=$ Buprenorphine; NorBup $=$ Norbuprenorphine

b. Matrix Comparison:

Not Applicable. The device is only intended to be used with urine samples.

# 3. Clinical Studies:

1. Clinical Sensitivity: Not applicable.

2. Clinical Specificity: Not applicable.

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable): Not applicable.

B Clinical Cut-Off: Not applicable.   
C Expected Values/Reference Range: Not applicable.

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.